436 related articles for article (PubMed ID: 27975050)
1. Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Twede H; Vanzo R; Harward E; Hensel CH; Martin MM; Page S; Peiffer A; Mowery-Rushton P; Serrano M; Wassman ER
Biomed Res Int; 2016; 2016():3284534. PubMed ID: 27975050
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
4. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
[TBL] [Abstract][Full Text] [Related]
5. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
Shin S; Yu N; Choi JR; Jeong S; Lee KA
Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
8. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M
Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
[TBL] [Abstract][Full Text] [Related]
10. Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices.
Peabody J; Martin M; DeMaria L; Florentino J; Paculdo D; Paul M; Vanzo R; Wassman ER; Burgon T
PLoS One; 2016; 11(12):e0169064. PubMed ID: 28036350
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.
Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH
Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patients.
Perovic D; Damnjanovic T; Jekic B; Dusanovic-Pjevic M; Grk M; Djuranovic A; Rasic M; Novakovic I; Maksimovic N
J Clin Lab Anal; 2022 Jun; 36(6):e24441. PubMed ID: 35441737
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation.
Hu T; Zhang Z; Wang J; Li Q; Zhu H; Lai Y; Wang H; Liu S
Biomed Res Int; 2019; 2019():9352581. PubMed ID: 31781653
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal microarray analysis of Bulgarian patients with epilepsy and intellectual disability.
Peycheva V; Kamenarova K; Ivanova N; Stamatov D; Avdjieva-Tzavella D; Alexandrova I; Zhelyazkova S; Pacheva I; Dimova P; Ivanov I; Litvinenko I; Bozhinova V; Tournev I; Simeonov E; Mitev V; Jordanova A; Kaneva R
Gene; 2018 Aug; 667():45-55. PubMed ID: 29753047
[TBL] [Abstract][Full Text] [Related]
16. Clinical Application of Chromosome Microarray Analysis in Han Chinese Children with Neurodevelopmental Disorders.
Xu M; Ji Y; Zhang T; Jiang X; Fan Y; Geng J; Li F
Neurosci Bull; 2018 Dec; 34(6):981-991. PubMed ID: 29948840
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.
Kim HJ; Park CI; Lim JW; Lee GM; Cho E; Kim HJ
Yonsei Med J; 2018 May; 59(3):431-437. PubMed ID: 29611406
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal microarray testing influences medical management.
Coulter ME; Miller DT; Harris DJ; Hawley P; Picker J; Roberts AE; Sobeih MM; Irons M
Genet Med; 2011 Sep; 13(9):770-6. PubMed ID: 21716121
[TBL] [Abstract][Full Text] [Related]
19. Array-CGH increased the diagnostic rate of developmental delay or intellectual disability in Taiwan.
Lee CL; Lee CH; Chuang CK; Chiu HC; Chen YJ; Chou CL; Wu PS; Chen CP; Lin HY; Lin SP
Pediatr Neonatol; 2019 Aug; 60(4):453-460. PubMed ID: 30581099
[TBL] [Abstract][Full Text] [Related]
20. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
